Search   
 Display As Presentations  Sessions
  Click Here for a Print-Friendly Version of this Page
Presentation Number:
H-1137c
Abstract Title:
The Combination of Tenofovir DF (TDF), Emtricitabine (FTC) and Efavirenz (EFV) Has Significantly Greater Response vs Fixed Dose Zidovudine/Lamivudine(CBV) and EFV in Antiretroviral Naive Patients: A 24 week Preliminary Analysis
Presentation Start/End Time:
Sunday, Oct 31, 2004, 4:20 PM - 4:30 PM
Author Block:
B. GAZZARD1, E. DEJESUS 2, R. CAMPO 3, J. JEMSEK 4, J. E. GALLANT 5, J. R. ARRIBAS 6, A. L. POZNIAK 1, B. LU 7, M. D. MILLER 7, J. ENEJOSA 7, A. CHENG 7, for the Study 934 Team;
1Chelsea & Westminster Hosp, London, United Kingdom, 2IDC Research, Altamonte Springs, FL, 3Univ Miami, Miami, FL, 4Jemsek Clinic, Huntersville, NC, 5Johns Hopkins Univ, Baltimore, MD, 6Univ Hosp La Paz, Madrid, Spain, 7Gilead Sciences, Foster City, CA.
Topic:
H
Keywords:
tenofovir DF,emtricitabine,Antiretroviral Naive
Commercial Relationship:
  B. Gazzard, Gilead Sciences P.
 
 
American Society for Microbiology
1752 N Street N.W.
Washington, D.C. 20036
Phone: (202) 737-3600
The Online Abstract Submission and Invitation System
© 1996 - 2010 Coe-Truman Technologies, Inc. All rights reserved.